BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy
10 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 10, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig to Present Clinical Observations at Venice Arrhythmias 2019
30 sept. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors
26 sept. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address...
BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic
12 sept. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
SetPoint Medical Appoints Anna Gawlicka as VP of Clinical Affairs
10 sept. 2019 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka,...
BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million
05 sept. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address...
BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System
01 août 2019 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
24 juil. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, July 24, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform...
Olivier Chaudoir Joins BioSig as Director of Marketing
18 juil. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform...
BioSig Technologies, Inc. to Receive 15 Units of PURE EP™ System from Manufacturer for Commercial Installation - Corrected Version
15 juil. 2019 10h45 HE
|
BioSig Technologies, Inc.
Westport, CT, July 15, 2019 (GLOBE NEWSWIRE) -- 1) New units to be prepped for next phase of targeted commercial launch strategy 2) Company includes 3 additional hospitals to its list...